chr16-572565-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004204.5(PIGQ):​c.-9-1501A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.474 in 455,356 control chromosomes in the GnomAD database, including 53,024 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 16187 hom., cov: 33)
Exomes 𝑓: 0.48 ( 36837 hom. )

Consequence

PIGQ
NM_004204.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0170
Variant links:
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-572565-A-G is Benign according to our data. Variant chr16-572565-A-G is described in ClinVar as [Benign]. Clinvar id is 1185510.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.62 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PIGQNM_004204.5 linkuse as main transcriptc.-9-1501A>G intron_variant ENST00000321878.10
PIGQNM_148920.4 linkuse as main transcriptc.-9-1501A>G intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PIGQENST00000321878.10 linkuse as main transcriptc.-9-1501A>G intron_variant 1 NM_004204.5 P1Q9BRB3-2

Frequencies

GnomAD3 genomes
AF:
0.457
AC:
69171
AN:
151308
Hom.:
16155
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.476
Gnomad AMI
AF:
0.369
Gnomad AMR
AF:
0.478
Gnomad ASJ
AF:
0.375
Gnomad EAS
AF:
0.638
Gnomad SAS
AF:
0.629
Gnomad FIN
AF:
0.506
Gnomad MID
AF:
0.333
Gnomad NFE
AF:
0.415
Gnomad OTH
AF:
0.406
GnomAD3 exomes
AF:
0.495
AC:
63591
AN:
128376
Hom.:
16495
AF XY:
0.500
AC XY:
35130
AN XY:
70298
show subpopulations
Gnomad AFR exome
AF:
0.476
Gnomad AMR exome
AF:
0.547
Gnomad ASJ exome
AF:
0.372
Gnomad EAS exome
AF:
0.614
Gnomad SAS exome
AF:
0.622
Gnomad FIN exome
AF:
0.520
Gnomad NFE exome
AF:
0.411
Gnomad OTH exome
AF:
0.421
GnomAD4 exome
AF:
0.482
AC:
146510
AN:
303930
Hom.:
36837
Cov.:
0
AF XY:
0.493
AC XY:
85379
AN XY:
173046
show subpopulations
Gnomad4 AFR exome
AF:
0.485
Gnomad4 AMR exome
AF:
0.547
Gnomad4 ASJ exome
AF:
0.375
Gnomad4 EAS exome
AF:
0.616
Gnomad4 SAS exome
AF:
0.619
Gnomad4 FIN exome
AF:
0.513
Gnomad4 NFE exome
AF:
0.422
Gnomad4 OTH exome
AF:
0.453
GnomAD4 genome
AF:
0.457
AC:
69255
AN:
151426
Hom.:
16187
Cov.:
33
AF XY:
0.466
AC XY:
34492
AN XY:
73998
show subpopulations
Gnomad4 AFR
AF:
0.476
Gnomad4 AMR
AF:
0.479
Gnomad4 ASJ
AF:
0.375
Gnomad4 EAS
AF:
0.638
Gnomad4 SAS
AF:
0.628
Gnomad4 FIN
AF:
0.506
Gnomad4 NFE
AF:
0.415
Gnomad4 OTH
AF:
0.412
Alfa
AF:
0.425
Hom.:
2492
Bravo
AF:
0.450
Asia WGS
AF:
0.661
AC:
2297
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 71% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 66. Only high quality variants are reported. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Developmental and epileptic encephalopathy, 77 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.9
DANN
Benign
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12917944; hg19: chr16-622565; API